MELAIU, OMBRETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.161
AS - Asia 1.510
EU - Europa 1.204
SA - Sud America 255
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.162
Nazione #
US - Stati Uniti d'America 2.112
SG - Singapore 644
IT - Italia 520
CN - Cina 224
BR - Brasile 219
HK - Hong Kong 204
RU - Federazione Russa 186
VN - Vietnam 142
IE - Irlanda 119
BD - Bangladesh 86
JP - Giappone 76
DE - Germania 75
FI - Finlandia 74
NL - Olanda 65
GB - Regno Unito 50
IN - India 32
FR - Francia 28
CA - Canada 27
ID - Indonesia 20
AT - Austria 16
ES - Italia 16
MX - Messico 15
SE - Svezia 15
AR - Argentina 13
IQ - Iraq 11
TR - Turchia 11
EC - Ecuador 10
PL - Polonia 10
ZA - Sudafrica 8
MA - Marocco 7
MY - Malesia 7
TH - Thailandia 7
KR - Corea 6
PH - Filippine 6
UA - Ucraina 5
UZ - Uzbekistan 5
AL - Albania 4
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
PK - Pakistan 4
DZ - Algeria 3
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
EG - Egitto 2
GI - Gibilterra 2
IR - Iran 2
JM - Giamaica 2
KW - Kuwait 2
LT - Lituania 2
LV - Lettonia 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SV - El Salvador 1
VE - Venezuela 1
Totale 5.162
Città #
Singapore 381
San Jose 298
Hong Kong 202
Rome 179
Chandler 146
Ashburn 124
Dublin 119
New York 105
Council Bluffs 99
Beijing 82
Los Angeles 79
Tokyo 71
The Dalles 58
Santa Clara 57
Wilmington 57
Buffalo 46
Helsinki 40
Chicago 39
Ho Chi Minh City 37
Hanoi 36
Fairfield 34
Milan 33
São Paulo 31
Lappeenranta 28
Moscow 28
Ann Arbor 26
Dallas 20
Colorado Springs 18
Frankfurt am Main 18
Houston 18
London 18
Brooklyn 17
Munich 17
Salt Lake City 17
Indianapolis 16
Medford 16
Jakarta 12
Lauterbourg 12
Seattle 12
Montreal 11
Atlanta 10
Da Nang 10
Elk Grove Village 10
Genoa 10
Nuremberg 10
Tampa 10
Vienna 10
Woodbridge 10
Würzburg 10
Amsterdam 9
Orem 9
Redondo Beach 9
Cambridge 8
Lawrence 8
Naples 8
San Diego 8
Bangkok 7
Chennai 7
McDonough 7
Mülheim 7
Phoenix 7
Belo Horizonte 6
Boardman 6
Boston 6
Des Moines 6
Engelhard 6
Haiphong 6
Lancaster 6
Manchester 6
Miami 6
Monte Vista 6
North Bergen 6
Seoul 6
Turin 6
Warsaw 6
Bologna 5
Charlotte 5
Denver 5
Guangzhou 5
Hounslow 5
Newark 5
Philadelphia 5
Quito 5
Rio de Janeiro 5
Stockholm 5
Toronto 5
Catania 4
Center 4
Columbus 4
Detroit 4
Fortaleza 4
Hyderabad 4
Johannesburg 4
Manila 4
Marseille 4
Mexico City 4
Mumbai 4
New Delhi 4
Nha Trang 4
Palermo 4
Totale 3.036
Nome #
ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of beta TrCP 176
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors 172
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 171
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 149
Autophagy inhibition enhances T and NK immunogenicity in neuroblastoma 143
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function 143
Quantification of the immune content in neuroblastoma: Deep learning and topological data analysis in digital pathology 139
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma 137
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 116
PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 114
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 105
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 101
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 100
News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors 95
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 89
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 87
Identification of overexpressed genes in malignant pleural mesothelioma 85
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma 84
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 84
Immunogenic cell death inducers in cancer immunotherapy to turn cold tumors into hot tumors 84
Neoadjuvant Treatment as a Risk Factor for Variation of Upper Limb Lymph Node Drainage During Axillary Reverse Mapping in Breast Cancer: A Prospective Observational Study 84
The genetic susceptibility in the development of malignant pleural mesothelioma 83
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma 81
Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment 80
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 80
Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 80
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 78
Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis 77
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma 77
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. 76
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 75
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 75
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 74
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 74
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 73
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 73
ERAP1 and ERAP2 enzymes: A protective shield for ras against COVID-19? 72
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing 72
A Novel Panel of Serum Biomarkers for MPM Diagnosis 71
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 71
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy 71
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 71
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 70
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 67
Eif4g1 and ran as possible drivers for malignant pleural mesothelioma 65
Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide 63
Expression status of candidate genes in mesothelioma tissues and cell lines 62
A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors 60
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 60
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays 59
Impact of natural occurring erap1 single nucleotide polymorphisms within mirna-binding sites on hcmv infection 58
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 57
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935) 56
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 55
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity 55
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme 54
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 54
Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases 52
Risk of differentiated thyroid carcinoma and polymorphisms within the susceptibility cancer region 8q24 50
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy 48
Correction: Inhibition of autophagy enhances the antitumor efficacy of T/CAR T cell against neuroblastoma 42
The regulatory roles of phosphatases in cancer 42
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 41
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes 40
Mapping B cells and the immune landscape of tertiary lymphoid structures reveals their clinical impact in neuroblastoma 38
Editorial: Community series in cell network in antitumor immunity of pediatric and adult solid tumors, volume II 34
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade 32
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer 13
Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation 11
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas 11
Transforming growth factor β induced as a novel secreted immune checkpoint counterinhibiting human tumor-associated T cells 10
Totale 5.401
Categoria #
all - tutte 30.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202287 27 6 1 0 0 9 5 3 6 3 4 23
2022/2023503 8 7 44 48 52 118 60 28 56 15 57 10
2023/2024247 27 16 20 6 35 62 12 7 12 19 4 27
2024/20251.410 21 214 133 103 45 199 84 43 87 93 282 106
2025/20262.856 217 117 222 186 253 92 471 284 341 245 224 204
2026/2027141 141 0 0 0 0 0 0 0 0 0 0 0
Totale 5.401